Liu, Yongqing <br/><br/>
Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.  [electronic resource] 

 -  The journal of gene medicine  Aug 2003 
 - 668-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1099-498X 
<br/><br/><label>Standard No.: </label>10.1002/jgm.387  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Adjuvants, Immunologic--metabolism<br/>Animals<br/>Cancer Vaccines<br/>Cell Line, Tumor<br/>Cell Movement--physiology<br/>Chemokines--metabolism<br/>Cytokines--metabolism<br/>Dendritic Cells--immunology<br/>Female<br/>Humans<br/>Immune System--physiology<br/>Killer Cells, Natural--immunology<br/>Membrane Proteins--genetics<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Neoplasms--immunology<br/>Survival Rate<br/>T-Lymphocytes--cytology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Transgenes